[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634739":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":24,"locations":33,"responsibleParty":57,"collaborators":61,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":69,"sex":75,"minAge":76,"maxAge":12,"enrollmentInfo":77,"targetDuration":12,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":97,"overallStatus":36,"whyStopped":12,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"Region of Southern Denmark","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care","NO_INTERVENTION","Lung cancer investigation only",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Tailored COPD consultation","EXPERIMENTAL","Tailored COPD consultations will include assessment and treatment according to GOLD guidelines, including:\n\nPharmacological management Smoking cessation support Referral to pulmonary rehabilitation as appropriate Referral for nutritional assessment and optimization when appropriate Referral to cardiovascular evaluation when appropriate Referral to sleep apnea evaluation when appropriate",[18],"Other: Tailored COPD consultations",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"Tailored COPD consultations","These consultations will include assessment and treatment according to GOLD guidelines, including:\n\nPharmacological management Smoking cessation support Referral to pulmonary rehabilitation as appropriate Referral for nutritional assessment and optimization when appropriate Referral to cardiovascular evaluation when appropriate Referral to sleep apnea evaluation when appropriate",[14],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},"Ditte Krag-Hansen, MD, PhD student","CONTACT","+45 7940 5720","ditte.krag-hansen@rsyd.dk",{"name":31,"role":27,"phone":12,"phoneExt":12,"email":32},"Morten Hornemann Borg, MD, PhD, Chief consultant","morten.hornemann.borg@rsyd.dk",[34],{"facility":35,"status":36,"city":37,"state":12,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Lung Cancer Investigation Unit, Lillebaelt Hospital Vejle","RECRUITING","Vejle","7100","Denmark","DK",{"type":42,"coordinates":43},"Point",[44,45],9.5357,55.70927,{"lat":45,"lon":44},[48,49,51,53,55],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},{"name":31,"role":50,"phone":12,"phoneExt":12,"email":12},"SUB_INVESTIGATOR",{"name":52,"role":50,"phone":12,"phoneExt":12,"email":12},"Anders Løkke, MD, PhD, Professor, Consultant",{"name":54,"role":50,"phone":12,"phoneExt":12,"email":12},"Ingeborg Farver-Vestergaard, PsyD, PhD, Associate Professor",{"name":26,"role":56,"phone":12,"phoneExt":12,"email":12},"PRINCIPAL_INVESTIGATOR",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"SPONSOR_INVESTIGATOR","Ditte Krag-Hansen","Principal Investigator",[62,65],{"name":63,"class":64},"AstraZeneca","INDUSTRY",{"name":66,"class":6},"Sygehus Lillebaelt","100634739","enhanced-copd-management-in-suspected-lung-cancer-patients-100634739",false,"NCT07543601","Enhanced COPD Management in Suspected Lung Cancer Patients","Enhanced COPD Management in Suspected Lung Cancer Patients - Improving Outcomes Through Timely Intervention","ECHELON","Inclusion Criteria:\n\n* Undergoing diagnostic evaluation for suspected lung cancer\n* Spirometry showing obstructive airflow limitation (FEV₁\u002FFVC \\\u003C 75 % or FEV₁ \\\u003C 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation\n\nExclusion Criteria:\n\n* Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry\n* Pregnant or breastfeeding women","ALL","18 Years",{"count":78,"type":79},280,"ESTIMATED","INTERVENTIONAL",[82],"NA","Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.\n\nThis study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle.\n\nThe findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.",[85,86,87,88,89,90,91,92,93,94,95,96],"COPD (Chronic Obstructive Pulmonary Disease)","Lung Cancer (Diagnosis)","Lung Neoplasm Malignant","Lung Carcinoma","Pulmonary Neoplasms","Pulmonary Neoplasm","Pulmonary Cancers","Pulmonary Cancer","Pulmonary Carcinoma","COPD","COPD - Chronic Obstructive Pulmonary Disease","Airflow Obstruction, Chronic",[98,99,100,101],"Invesigation","Evaluation","Diagnostic Work-up","Diagnostic Pathway","2026-04-15",{"date":104,"type":105},"2026-04-22","ACTUAL",{"date":107,"type":105},"2026-03-06",{"date":109,"type":79},"2027-06-30",{"name":59,"class":6},1]